Literature DB >> 2760640

Inhibition of carnitine palmitoyltransferase (CPT) by chlorpromazine in muscle of patients with CPT deficiency.

S Zierz, S Neumann-Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2760640     DOI： 10.1007/BF00314510

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Mutant carnitine palmitoyltransferase associated with myoadenylate deaminase deficiency in skeletal muscle.

Authors:  C Reuschenbach; S Zierz
Journal:  J Pediatr       Date:  1988-04       Impact factor: 4.406

2.  Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA.

Authors:  J D McGarry; G F Leatherman; D W Foster
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

3.  Chlorpromazine and carnitine-dependency of rat liver peroxisomal beta-oxidation of long-chain fatty acids.

Authors:  J Vamecq
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

4.  Different sites of inhibition of carnitine palmitoyltransferase by malonyl-CoA, and by acetyl-CoA and CoA, in human skeletal muscle.

Authors:  S Zierz; A G Engel
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

5.  Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle.

Authors:  S Zierz; A G Engel
Journal:  Eur J Biochem       Date:  1985-05-15

6.  Partition of chlorpromazine into lipid bilayer membranes: the effect of membrane structure and composition.

Authors:  M Luxnat; H J Galla
Journal:  Biochim Biophys Acta       Date:  1986-04-14

7.  ESR spectral changes induced by chlorpromazine in spin-labeled erythrocyte ghost membranes.

Authors:  T Yamaguchi; S Watanabe; E Kimoto
Journal:  Biochim Biophys Acta       Date:  1985-11-07
  7 in total
  1 in total

Review 1.  On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.